Eric A Pierce

Title: Eric A Pierce: Innovator in Gene Therapy

Introduction

Eric A Pierce is a prominent inventor based in Belmont, MA (US), known for his significant contributions to the field of gene therapy. He holds 2 patents that focus on innovative approaches to treat genetic disorders, particularly those affecting vision and hearing.

Latest Patents

His latest patents include a CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome. This invention involves compositions for treating subjects with USH2A-associated retinal and/or cochlear degeneration resulting from mutations in exon 13 of the USH2A gene. The method includes the deletion of exon 13 from the USH2A gene or its transcripts, along with the development of genetically modified animals and cells. Another notable patent is for gene therapy targeting NMNAT1-associated retinal degeneration. This patent outlines methods and compositions for gene therapy related to mutations in nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1).

Career Highlights

Throughout his career, Eric has worked with esteemed organizations such as the Massachusetts Eye and Ear Infirmary and Editas Medicine, Inc. His work has significantly advanced the understanding and treatment of genetic conditions affecting vision and hearing.

Collaborations

Eric has collaborated with notable professionals in his field, including Luk H Vandenberghe and Scott Greenwald. These partnerships have contributed to the development of innovative therapies and have enhanced the impact of his research.

Conclusion

Eric A Pierce is a leading figure in the field of gene therapy, with a focus on innovative solutions for genetic disorders. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.